Acquired
XinThera Stock
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Sign up today and learn more about XinThera Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About XinThera Stock
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Funding History
| 2021-08-01 | $50.0M |
|---|
Management
Board Member
Carl L. Gordon
Co-founder and Senior Vice President
Gene Hung
Board Member
Michael Rome
Co-Founder and Chairman
Stephen Kaldor
Board Member
Jim Tananbaum
President & CSO
Qing Dong
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
